0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Not currently available

Novartis Foundation Symposium 274 - Heart Failure - Molecules, Mechanisms and Therapeutic Targets (Hardcover) Loot Price: R4,635
Discovery Miles 46 350
Novartis Foundation Symposium 274 - Heart Failure - Molecules, Mechanisms and Therapeutic Targets (Hardcover): Novartis

Novartis Foundation Symposium 274 - Heart Failure - Molecules, Mechanisms and Therapeutic Targets (Hardcover)

Novartis

 (sign in to rate)
Loot Price R4,635 Discovery Miles 46 350 | Repayment Terms: R434 pm x 12*

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dramatic progress has been made in unravelling the cellular circuitry involved in cardiac failure, as well as in normal cardiac growth, development and apoptosis. This work has revealed new and unexpected therapeutic targets in the heart. In addition, advances in understanding the role of stem cells in cardiac physiology have suggested strategies for cardiac repair and regeneration once thought impossible.

This book describes the work of leading investigators studying the basic mechanisms of cardiac growth, function and dysfunction. There are also exciting contributions from researchers developing novel therapeutic strategies for cardiac disease. The unique feature is the discussions amongst the contributors, which always return to the same basic problem: how can new data from biological studies be used to design novel therapies for the treatment of cardiac dysfunction following myocardial infarction, hypertension and other disorders?

With its strong emphasis on translational research, this book will appeal to both scientists and clinicians interested in diminishing the impact of the current epidemic of cardiac diseases.

General

Imprint: John Wiley & Sons
Country of origin: United States
Release date: July 2006
First published: September 2006
Authors: Novartis
Dimensions: 235 x 185 x 19mm (L x W x T)
Format: Hardcover
Pages: 302
ISBN-13: 978-0-470-01597-1
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
LSN: 0-470-01597-7
Barcode: 9780470015971

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners